Tag: psychiatry
Impact of COVID-19 Pandemic on Psychiatric Patients at Clinical Trial Sites
by Maria Fe Garcia-Rada, MPS, and Robert E. Litman, MD Ms. Garcia-Rada and Dr. Litman are with CenExel CBH Health in Gaithersburg, Maryland. Dr. Litman is with Georgetown University Medical School in Washington, DC. Funding: Funding was provided by CenExel Clinical Research. Disclosures: Dr. Litman is a member of the Speaker’s Bureau for Janssen, AbbVie, […]
Psychotherapy for Adult ADHD
by Kari Harper, MD, and Julie P. Gentile, MD, MBA Dr. Harper is Assistant Professor and Dr. Gentile is Professor and Chair of the Department of Psychiatry at Wright State University in Dayton, Ohio. Funding: No funding was provided for this study. Disclosures: The authors have no conflicts of interest relevant to the content of […]
Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic
by Robert E. Litman, MD; Peter Sorantin, PhD; and Elia E. Acevedo-Diaz, MD Drs. Litman is with CBH Health, Georgetown University Medical School in Washington, DC. Dr. Sorantin is with Sorantin Outcomes, LLC, in Mountain Lakes, New Jersey. Dr. Acevedo-Diaz is with CBH Health and the National Institute of Mental Health (NIMH) in Bethesda, Maryland. […]
Exploring the Potential Psychiatric Implications of Astronomical Phenomena
by Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP; Michaela Camille Lysogorski, PharmD; and Eileen Trigoboff, RN, RMHCNS-BC, DNS, DABFN Drs. Demler and Trigoboff are with the University of Buffalo, School of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy Practice, in Buffalo, New York, University of Buffalo, School of Medicine, Department of Psychiatry in Buffalo, […]
It’s Nice to Be Nice, But…A Little Risk Management Can Go a Long Way in Reducing Your Liability Risk
by Donna Vanderpool, MBA, JD Ms. Vanderpool is Vice President at PRMS, Inc. in Arlington, Virginia. Funding: No funding was provided for the preparation of this article. Disclosures: The author is an employee of PRMS Inc., a risk management consulting company for healthcare providers. Innov Clin Neurosci. 2018;15(11–12):36–38 This ongoing column is dedicated to providing […]
CNS Summit 2017 Abstracts of Poster Presentations
Innov Clin Neurosci. 2017;14(11–12)S1—S20. A Message From the Editor: Dear Colleagues: Welcome to the annual CNS Summit Abstracts of Poster Presentations supplement to Innovations in Clinical Neuroscience. We are pleased to provide you with this reference guide to some of the innovative research that is being presented during CNS Summit 2017. This supplement is just a […]
Neuroendocrine, Autonomic, and Metabolic Responses to an Orexin Antagonist, Suvorexant, in Psychiatric Patients with Insomnia
by Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital, in Hiroshima, Japan, and Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, in Yamaguchi, Japan. Innov Clin Neurosci. 2017;14(3–4):30–37. Funding: No funding was received for the preparation […]
CNS Summit 2016 Abstracts of Poster Presentations
Innov Clin Neurosci. 2017;14(1–2)3–23. A MESSAGE FROM THE EDITOR Dear Colleagues: Welcome to the annual CNS Summit Abstracts of Poster Presentations supplement to Innovations in Clinical Neuroscience. We are pleased to provide you with this reference guide to some of the innovative research that was presented during CNS Summit 2016, which was held October 27 […]
Editor’s Message: September–October 2016 Issue Highlights
Dear Colleagues: Welcome to the September-October 2016 issue of Innovations in Clinical Neuroscience (ICNS). As the official journal of the CNS Summit, the International Society for CNS Drug Development (ISCDD), and the International Society for CNS Clinical Trials and Methodology (ISCTM), an important part of our editorial mission is to accelerate and enhance the development […]
Brain Health Executives: A Transdisciplinary Workforce Innovation—A Commentary
by Harris A. Eyre, MBBS (hons.), PhD; Michael Berk, MD, PhD; Erin Smith; Jeffrey Cummings, MD, ScD; and Mark Heinemeyer, MSc Dr. Eyre and Mr. Heinemeyer are co-founders of the PRODEO Institute. Dr. Eyre is with the PRODEO Institute in San Francisco, California; the Institute for Mental and Physical Health and Clinical Translation (IMPACT) and […]
Continue Reading